Kontrol BioWater Technology completes Successful Phase 1 Viral Detection in Wastewater: Advancing Biomonitoring Technology
TORONTO - Kontrol Technologies Corp. (NEO:KNR) (OTCQB:KNRLF) (FSE:1K8) (“Kontrol” or the “Company”), a leader in smart buildings and cities has successfully completed its Phase 1 testing of the Kontrol BioWater technology (or “BioWater”) with a positive detection of the Sars-Cov-2 virus in wastewater.
“We are very pleased that our Kontrol BioWater technology was able to deliver a positive result as part of Phase 1 testing,” says Paul Ghezzi, CEO of Kontrol Technologies. “There is a growing emphasis on biomonitoring technology to help governments and private enterprise better manage how they monitor and plan for viral outbreaks. We look forward to advancing this important proprietary technology.”
Phase 1 Testing
The Kontrol BioWater wastewater viral detection Phase 1 testing was completed with support from the National Research Council of Canada. The BioWater utilizes the core scientific technique of a Modified Western Blot to identify viruses.
Kontrol was provided with wastewater samples from various facilities in Ontario. Those samples were independently tested by government contracted labs utilizing the reference method of qPCR analysis to validate positive detection and quantification of the SARs-CoV-2 virus.
“We are thrilled with our successful Phase 1 testing and look forward to the next steps in building out the Kontrol BioWater technology,” says Gary Saunders, President of Kontrol BioCloud. “We have initiated our prototype design which will form the basis of our real-time detection solution.”
What makes Kontrol BioWater Unique
The Kontrol BioWater technology is designed with the goal of being the first real-time, in the cloud, detection technology for virus in wastewater. The current process for the collection of wastewater sampling involves on-site technicians, transporting samples to a laboratory and then undertaking a separate analysis of the wastewater. This process is time consuming and can take several days to complete. The intention of the Kontrol BioWater is to advance sampling automation for faster, on-site detection which can potentially accelerate a response plan.
Kontrol BioWater Innovation
The Company has launched the development of the Kontrol BioWater, including advancing a prototype design, and to date has received $300,000 in research and development funding for the initial Phase 1 testing. The Company has demonstrated a successful track record in accessing Federal and Provincial funding for its Kontrol BioCloud technology. However, there is no assurance that the Company will receive any further government funding.
Wastewater Surveillance
According to the CDC wastewater data can help scientists detect SARS-CoV-2, the virus that causes COVID-19, in a community even before data from doctor’s offices or hospitals get reported to public health officials. Wastewater data can be an important early warning signal and should be used alongside other data. Early warning systems, such as wastewater surveillance, can detect small changes as a signal for early action. More data over time can give better, more reliable trends. www.cdc.gov/healthywater/surveillance
The Company is not making any express or implied claims that its product has the ability to eliminate, cure or contain the COVID-19 (or SARS-2 Coronavirus).
About Kontrol BioWater
Kontrol BioWater is a technology extension of the Kontrol BioCloud and will be developed to operate as a branded solution for wastewater monitoring applications.
Kontrol Technologies Corp.
Kontrol Technologies Corp., a Canadian public company, is a leader in smart buildings and cities through IoT, Cloud and SaaS technology. Kontrol provides solutions and services to its customers to improve energy management, monitor continuous emissions and accelerate the sustainability of all buildings.
Additional information about Kontrol Technologies Corp. can be found on its website at www.kontrolcorp.com and by reviewing its profile on SEDAR at www.sedar.com.
https://facebook.com/kontroltechcorp/
https://twitter.com/kontrolgroup
https://www.linkedin.com/company/kontrol-group
Neither IIROC nor any stock exchange or other securities regulatory authority accepts responsibility for the adequacy or accuracy of this release.
Forward-Looking Statements
This news release contains “forward-looking information” within the meaning of applicable securities laws. All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions, and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy. Forward-looking information contained in this press releases includes, but is not limited to, the following: future testing to be conducted by Kontrol of its products; the future success of any of Kontrol’s products; and customer demand relating to air quality and water testing products.
Where Kontrol expresses or implies an expectation or belief as to future events or results, such expectation or belief is based on assumptions made in good faith and believed to have a reasonable basis. Such assumptions include, without limitation, that sufficient capital will be available to the Company; that future testing can be conducted as planned; that technology will be as effective as anticipated; that existing relationships and contracts entered into by the Company will continue on the same or similar terms, or at all; and that demand will continue for air quality or water monitoring products and for the Company’s products in particular.
However, forward-looking statements are subject to risks, uncertainties, and other factors, which could cause actual results to differ materially from future results expressed, projected, or implied by such forward-looking statements. Such risks include, but are not limited to, that sufficient capital and financing cannot be obtained on reasonable terms, or at all; that the Company’s technologies will not prove as effective as expected; that customers and potential customers will not be as accepting of the Company's product and service offering as expected and/or that demand for such products and services will not continue; that the Company’s test results will not be replicated in the future or that future testing will not be conducted; that the Company will not maintain its existing relationships or contracts on the same terms or at all; and government and regulatory factors impacting the energy conservation industry. Kontrol BioCloud is an air quality technology and not a medical device. The Company is not making any express or implied claims that its product has the ability to eliminate, cure or contain the COVID-19 (or SARS-2 Coronavirus).
Accordingly, undue reliance should not be placed on forward-looking statements and the forward-looking statements contained in this press release are expressly qualified in their entirety by this cautionary statement. The forward-looking statements contained herein are made as at the date hereof and are based on the beliefs, estimates, expectations, and opinions of management on such date. Kontrol does not undertake any obligation to update publicly or revise any such forward-looking statements or any forward-looking statements contained in any other documents whether as a result of new information, future events or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required under applicable securities law. Readers are cautioned to consider these and other factors, uncertainties, and potential events carefully and not to put undue reliance on forward-looking information.
Contacts
Kontrol Technologies Corp.
Paul Ghezzi
CEO
info@kontrolcorp.com
11 Cidermill Avenue, Suite 201
Vaughan, Ontario L4K 4B6
Tel: (905) 766.0400